Cargando…
Myasthenic crisis and polymyositis induced by one dose of nivolumab
An 80‐year‐old man, who developed multiple lymph node and skin metastasis of malignant melanoma, received nivolumab monotherapy. Two weeks after the first dose, he experienced anorexia and fatigue, and suffered from progressive, severe dyspnea and muscle weakness. We diagnosed him with myocarditis,...
Autores principales: | Kimura, Toshihiro, Fukushima, Satoshi, Miyashita, Azusa, Aoi, Jun, Jinnin, Masatoshi, Kosaka, Takayuki, Ando, Yukio, Matsukawa, Masakazu, Inoue, Hiroyuki, Kiyotani, Kazuma, Park, Jae‐Hyun, Nakamura, Yusuke, Ihn, Hironobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946722/ https://www.ncbi.nlm.nih.gov/pubmed/27420474 http://dx.doi.org/10.1111/cas.12961 |
Ejemplares similares
-
Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia
por: Takamatsu, Koutaro, et al.
Publicado: (2018) -
Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma
por: Inoue, Hiroyuki, et al.
Publicado: (2016) -
Investigation of FOXM1 as a Potential New Target for Melanoma
por: Miyashita, Azusa, et al.
Publicado: (2015) -
Geographical Flushing of the Children's Face: A New Clinical Entity?
por: Jinnin, Masatoshi, et al.
Publicado: (2013) -
Myasthenic Crisis In Pregnancy
por: French, David M., et al.
Publicado: (2017)